Therapy News and Research

RSS

Scientists pinpoint potential treatment target for pediatric liver cancer

A protein in the cell nucleus already targeted therapeutically for several types of cancer has now been linked to an aggressive form of pediatric liver cancer called hepatoblastoma (HBL), according to a study published in the Nature journal Communications Biology.

11 Jun 2018

Synthetic gene reveals potential therapeutic target for rare, inherited disease

DNA Repair is essential for a healthy organism. In every day of our lives, tens of thousands of damages occur in the genetic material of our cells. Hence, it is not surprising that a broad variety of repair mechanisms developed in the course of evolution that enables cells to quickly react and patch up the affected DNA strands.

11 Jun 2018

CRISPR-Cas9 technique may raise cancer risk

Therapeutic use of gene editing with the so-called CRISPR-Cas9 technique may inadvertently increase the risk of cancer, according to a new study from Karolinska Institutet, Sweden, and the University of Helsinki, Finland, published in Nature Medicine.

11 Jun 2018

Novel computer models for individualization of HIV therapy in countries with limited healthcare resources

New predictive computer models designed to optimize HIV therapy in countries with limited healthcare resources are published online this week in the Journal of Antimicrobial Chemotherapy.

11 Jun 2018

Rural Vietnam village harbors multi-drug-resistant, colistin-resistant E. coli bacteria, shows study

A new study has found that the majority of residents in a rural village of Vietnam harbored multi-drug-resistant, colistin-resistant E. coli bacteria.

11 Jun 2018

Researchers reverse tau-induced memory deficits in animal models

Reversing memory deficits and impairments in spatial learning is a major goal in the field of dementia research. A lack of knowledge about cellular pathways critical to the development of dementia, however, has stood in the way of significant clinical advance.

8 Jun 2018

Alnylam announces new positive results from Phase 1/2 study of lumasiran in patients with PH1

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today new positive results from its Phase 1/2 study with lumasiran, an investigational RNAi therapeutic targeting glycolate oxidase for the treatment of Primary Hyperoxaluria Type 1.

8 Jun 2018

Biotheranostics presents key data for CancerTYPE ID and Breast Cancer Index at ASCO 2018

Biotheranostics, Inc. announces new data from studies for both of its proprietary molecular diagnostic tests, CancerTYPE ID and Breast Cancer Index to be presented on Saturday, June 2nd and Monday, June 4th at the annual meeting of the American Society of Clinical Oncology in Chicago.

8 Jun 2018

Customized resistance exercise helps female fibromyalgia patients improve health

Fibromyalgia and resistance exercise have often been considered an impossible combination. But with proper support and individually adjusted exercises, female patients achieved considerable health improvements, according to research carried out at Sahlgrenska Academy, Sweden.

8 Jun 2018

People using low rather than high nicotine e-cigarettes may be vaping more intensely, study finds

Vapers using low rather than high nicotine e-cigarettes may be using their devices more intensely, potentially increasing the risk of exposure to toxins in the vapour, according to new research funded by Cancer Research UK and published in Addiction today.

8 Jun 2018

Scientists find key biomarker of Parkinson's disease in the retina

A research involving scientists from the University of Alicante and the United States notes that the accumulation of a protein known as alpha-synuclein in the retina is a key Parkinson's biomarker that could help detect the degree of severity of the disease.

8 Jun 2018

Researchers discover new therapy combination that may help treat ovarian cancer

Researchers at The University of Kansas Cancer Center have discovered a therapy combination that may be helpful in the treatment of certain types of ovarian cancer.

8 Jun 2018

Researchers assess impact of sleep apnea treatment on diabetes management

For adults with diabetes, managing the disease is a day-in, day-out effort to control the factors that affect blood sugar levels.

7 Jun 2018

Researchers develop model that predicts changes in BUP exposure during pregnancy

Buprenorphine (BUP) is approved for the treatment of opioid addiction. The current dosing regimen of BUP in pregnant women is based on recommendations designed for non-pregnant adults, but physiological changes during pregnancy may alter BUP exposure and efficacy.

7 Jun 2018

Foam rollers help patients to recover from injuries

Foam rollers have become more prevalent in gyms, exercise classes and therapy clinics over the last 10 years.

7 Jun 2018

Study finds high insurance denial rates for life-saving hepatitis C drugs in the U.S.

The number of insurance denials for life-saving hepatitis C drugs among patients with both private and public insurers remains high across the United States, researchers from the Perelman School of Medicine at the University of Pennsylvania reported in a new study published in the journal Open Forum Infectious Diseases.

7 Jun 2018

Study finds factors that help or hinder patient involvement in clinical trials of mitochondrial disease

As clinical trials gear up with the aim of attaining the first FDA-approved treatments for mitochondrial disease, a new study reports for the first time what patients and families say would motivate them for or against participating in such research trials.

7 Jun 2018

Therapy News and Research

Scientists pinpoint potential treatment target for pediatric liver cancer

Synthetic gene reveals potential therapeutic target for rare, inherited disease

CRISPR-Cas9 technique may raise cancer risk

Novel computer models for individualization of HIV therapy in countries with limited healthcare resources

Rural Vietnam village harbors multi-drug-resistant, colistin-resistant E. coli bacteria, shows study

Researchers reverse tau-induced memory deficits in animal models

Alnylam announces new positive results from Phase 1/2 study of lumasiran in patients with PH1

Biotheranostics presents key data for CancerTYPE ID and Breast Cancer Index at ASCO 2018

Customized resistance exercise helps female fibromyalgia patients improve health

People using low rather than high nicotine e-cigarettes may be vaping more intensely, study finds

Scientists find key biomarker of Parkinson's disease in the retina

Researchers discover new therapy combination that may help treat ovarian cancer

Researchers assess impact of sleep apnea treatment on diabetes management

Researchers develop model that predicts changes in BUP exposure during pregnancy

Foam rollers help patients to recover from injuries

Study finds high insurance denial rates for life-saving hepatitis C drugs in the U.S.

Study finds factors that help or hinder patient involvement in clinical trials of mitochondrial disease

Study finds clear predictors of rising A1c levels in young people with type 1 diabetes

Colorado researchers suggest new combination therapy for advanced head and neck cancer

New nuclear medicine method appears to effectively detect neuroendocrine tumors

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News